1. Lines J, Schapira A, Smith T. Tackling malaria today. BMJ. 2008;337:435–437.
2. Kahn JG, Basu S, Boyle C. Financing elimination. In: Feachem RGA, Phillips AA, Targett GAT, editors. Shrinking the malaria map: a prospectus on malaria elimination. The Global Health Group, Global Health Sciences, University of California, San Francisco; San Francisco: 2009.
3. Feachem RGA, Phillips AA, Targett GAT, editors. Shrinking the malaria map: a prospectus on malaria elimination. The Global Health Group, Global Health Sciences, University of California, San Francisco; San Francisco: 2009.
4. Mills A, Lubell Y, Hanson K. Malaria eradication: the economic, financial and institutional challenge. Malar J. 2008;7:11. [PMC free article] [PubMed]
5. Moonen B, Cohen JM, Snow RW. Operational strategies to achieve and maintain malaria elimination. Lancet. 2010 published online Oct 29.
6. Cohen JM, Smith DL, Moonen B, Snow RW. How absolute is zero? An evaluation of historical and current definitions of malaria elimination. Malar J. 2010;9:213. [PMC free article] [PubMed]
7. Mills A, Shillcutt S. Challenge paper on communicable diseases. In Copenhagen Consensus Center. Copenhagen Consensus 2004; Copenhagen: 2004.
8. Jamison DT. Cost effectiveness analysis: concepts and applications. In: Detels R, McEwen J, Beaglehole R, Tanaka H, editors. Oxford Textbook of Public Health: Volume 2, The Methods of Public Health. fifth edn. Oxford University Press; Oxford: 2009. pp. 767–782.
9. Edejer TT, Baltussen R, Adam T. WHO guide to cost-effectiveness analysis. World Health Organization; Geneva: 2003.
10. Feachem RGA, Phillips AA, Hwang J. Shrinking the malaria map: progress and prospects. Lancet. 2010 published online Oct 29.
11. Bart KJ, Foulds J, Patriarca P. Global eradication of poliomyelitis: benefit-cost analysis. Bull World Health Organ. 1996;74:35–45. [PubMed] 12. Khan MM, Ehreth J. Costs and benefits of polio eradication: a long-run global perspective. Vaccine. 2003;21:7–8. [PubMed]
13. Kim A, Ruiz-Tiben E. Cost-benefit analysis of the dracunculiasis eradication campaign. World Bank; Washington DC: 1997.
14. WHO World Health Organization Expert Committee on Malaria: Technical Report Series No. 123. Sixth Report. World Health Organization; Geneva: 1957.
15. Najera JA. Malaria control: achievements, problems, and strategies. World Health Organization; Geneva: 1999.
16. Yekutiel P. The Global Malaria Eradication Campaign. In: Yekutiel P, editor. Eradication of infectious diseases: a critical study. S. Karger; Basel, Switzerland: 1980. pp. 34–88.
17. Pampana E. A textbook of malaria eradication. Oxford University Press; London: 1969.
18. Moonen B, Barrett S, Tulloch J, Jamison DT. Shrinking the malaria map: a prospectus on malaria elimination. The Global Health Group, Global Health Sciences, University of California, San Francisco; San Francisco: 2009. Making the decision.
19. Ottersen T, Mbilinyi D, Maestad O, Norheim OF. Distribution matters: Equity considerations among health planners in Tanzania. Health Policy. 2008;85:218–227. [PubMed] 20. Jehu-Appiah C, Baltussen R, Acquah C. Balancing equity and efficiency in health priorities in Ghana: the use of multicriteria decision analysis. Value Health. 2008;1:1081–1087. [PubMed]
21. Lomborg B. Global Crises, Global Solutions. Cambridge University Press; Cambridge: 2009.
22. Goodman CA, Mills AJ. The evidence base on the cost-effectiveness of malaria control measures in Africa. Health Policy Plan. 1999;14:301–312. [PubMed] 23. Barrett S. Eradication versus control: the economics of global infectious disease policies. Bull World Health Organ. 2004;82:683–688. [PubMed] 24. Castro-Leal F, Dayton J, Demery L, Mehra K. Public spending on health care in Africa: do the poor benefit? Bull World Health Organ. 2000;78:66–74. [PubMed] 25. Cleary S. Trade-offs in scaling up HIV treatment in South Africa. Health Policy Plan. 2010;25:99–101. [PubMed] 26. Bleichrodt H, Diecidue E, Quiggin J. Equity weights in the allocation of health care: the rank-dependent QALY model. J Health Econ. 2004;23:157–171. [PubMed] 27. Ong KS, Kelaher M, Anderson I, Carter R. A cost-based equity weight for use in the economic evaluation of primary health care interventions: case study of the Australian Indigenous population. Int J Equity Health. 2009;8:34. [PMC free article] [PubMed] 28. Maartens F, Sharp B, Curtis B, Mthembu J. The impact of malaria control on perceptions of tourists and tourism operators concerning malaria prevalence in KwaZulu-Natal, 1999/2000 versus 2002/2003. J Travel Med. 2007;14:96–104. [PubMed] 29. Smith RD. Responding to global infectious disease outbreaks: lessons from SARS on the role of risk perception, communication and management. Soc Sci Med. 2006;63:3113–3123. [PubMed] 30. Brug J, Aro AR, Richardus JH. Risk perceptions and behaviour: towards pandemic control of emerging infectious diseases. Int J Behav Med. 2009;16:3–6. [PubMed] 31. Humphreys M. Kicking a dying dog. DDT and the demise of malaria in the American South, 1942–1950. Isis. 1996;87:1–17. [PubMed] 32. Litsios S. Which way for malaria control and epidemiological services? World Health Forum. 1993;14:43–52. [PubMed]
35. Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat, World Population Prospects: The 2008 Revision.
36. Tatem AJ, Smith DL, Gething PW, Kabaria CW, Snow RW, Hay SI. Ranking of elimination feasibility between malaria-endemic countries. Lancet. 2010 published online Oct 29.
37. China Annual Malaria Report, 2. Ministry of Health; Beijing: 2009.
38. International Monetary Fund World Economic Outlook Database. International Monetary Fund; Washington DC: 2009.
39. China Statistical Yearbook 2008. National Bureau of Statistics of China; China: 2008.
40. Lu C, Schneider MT, Gubbins P. Public financing of health in developing countries: a cross-national systematic analysis. Lancet. 2010;375:1375–1387. [PubMed]
41. WHO World Health Statistics. World Health Organization; Geneva: 2009.
42. UNICEF Immunization Summary. UNICEF; New York: 2009.
43. WHO Malaria elimination: a field manual for low and moderate endemic countries. World Health Organization; Geneva: 2007.
44. Thompson KM, Tebbens RJ. Eradication versus control for poliomyelitis: an economic analysis. Lancet. 2007;369:1363–1371. [PubMed]
45. Kaser MC. Observations on the likely economic efficiency of the malaria eradication program. In: Barlow R, editor. The economic effects of malaria eradication. University of Michigan School of Public Health; Michigan: 1968. pp. 145–167.
46. Briggs A, Sculpher M, Buxton M. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Econ. 1994;3:95–104. [PubMed] 47. Robberstad B, Strand T, Black R. Cost-effectiveness of zinc as adjunct therapy for acute childhood diarrhea in developing countries. Bull World Health Organ. 2004;82:523–531. [PubMed] 48. Akumu AO, English M, Scott JAG, Griffiths UK. Economic evaluation of delivering Haemophilus influenzae type b vaccine in routine immunization services in Kenya. Bull World Health Organ. 2007;85:511–518. [PMC free article] [PubMed]
49. Griffith ME. Financial implications of surveillance in India and other countries. Bull Nat Soc India Malaria Other Mosquito-borne Dis. 1961;9:385–411.
50. De Zulueta J, Muir DA. Malaria eradication in the near east. Trans R Soc Trop Med Hyg. 1972;66:679–695. [PubMed] 51. Cohn E. Assessing the costs and benefits of anti-malaria programs: the Indian experience. Am J Public Health. 1973;63:1086–1096. [PubMed]
52. Bleakley H. Malaria eradication in the Americas: a retrospective analysis of childhood exposure. Chicago; University of Chicago: 2008.
53. Cutler D, Fung W, Kremer M, Singhal M, Vogl T. Mosquitoes: The long-term effects of malaria eradication in India. NBER Work Pap Ser. 2007:13539.
54. Lucas AM. Malaria eradication and educational attainment: evidence from Paraguay and Sri Lanka. Am Econ J Appl Econ. 2010;2:46–71.
55. Ashraf QH, Lester A, Weil DN. When does improving health raise GDP? NBER Work Pap Ser. 2008:14449.
56. Celasun O, Walliser J. Predictability of Aid: Do Fickle Donors Undermine Aid Effectiveness. Econ Policy. 2008;23:545–594.
57. Johnson KA, Sardell A, Richards B. Federal immunization policy and funding: A history of responding to crises. Am J Prev Med. 2000;19:1–14. [PubMed] 58. Jackson S, Sleigh AC, Liu XL. Cost of malaria control in China: Henan's consolidation programme from community and government perspectives. Bull World Health Organ. 2002;80:653–659. [PubMed] 59. Soeung SC, Grundy J, Maynard J, Brooks A. Financial sustainability planning for immunization services in Cambodia. Health Policy Plan. 2006;21:302–309. [PubMed]
60. Najera JA, Kouznetsov RL, Delacollette C. Malaria epidemics, detection and control forecasting and prevention. World Health Organization Division of Control of Tropical Diseases; Geneva: 1998.
61. Sachs J. Achieving the millennium development goals—the case of malaria. NEJM. 2005;352:115–117. [PubMed]
62. Lazzari S. The black lung excise tax on coal. Congressional Research Service Report; Washington DC: 2004.
63. Drake B, Tieman AM. National childhood vaccine injury act of 1986: using tax revenue to assure vaccine availability. Public Budgeting Finance. 1994;14:54–64.
64. Lane C, Glassman A. Smooth and predictable aid for health: A role for innovative financing? Brookings Institution; Washington DC: 2009.
65. Yip K. Malaria eradication: the Taiwan experience. Parasitologia. 2000;42:117–126. [PubMed] 66. Feachem RGA, Sabot O. A new global malaria eradication strategy. Lancet. 2008;371:1633–1635. [PubMed] 67. Bhattarai A, Ali AS, Kachur SP. Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar. PLoS Med. 2007;4:e309. [PMC free article] [PubMed]
68. Barrett S, Hoel M. Optimal disease eradication. Environ Dev Econ. 2007;12:627–652.
69. Ministry of Health From Control to Elimination: A revised national malaria strategy 2010–2015. China Ministry of Health; Beijing: 2010.